Clinical implications of benign multiple sclerosis: a 20-year population-based follow-up study. - Wikidata - wikimedia - TriplyDB

Clinical implications of benign multiple sclerosis: a 20-year population-based follow-up study.

Clinical implications of benign multiple sclerosis: a 20-year population-based follow-up study.

http://www.wikidata.org/entity/Q34338580

about

Fingolimod for relapsing-remitting multiple sclerosis Fingolimod for relapsing remitting multiple sclerosis Role of health-related quality of life measures in the routine care of people with multiple sclerosis Clinical, MRI, and CSF markers of disability progression in multiple sclerosis.Comparison of brainstem reflex recordings and evoked potentials with clinical and MRI data to assess brainstem dysfunction in multiple sclerosis: a short-term follow-up.CXCL10 haplotypes and multiple sclerosis: association and correlation with clinical course.Allelic variation in the Tyk2 and EGF genes as potential genetic determinants of CNS repair.Global N-acetylaspartate declines even in benign multiple sclerosis Dynamic regulation of serum aryl hydrocarbon receptor agonists in MS Clinical characteristics of multiple sclerosis in Kuwait: data from the new MS registry of Amiri Hospital.Overcoming the clinical-MR imaging paradox of multiple sclerosis: MR imaging data assessed with a random forest approach.Exploring the predictive value of the evoked potentials score in MS within an appropriate patient population: a hint for an early identification of benign MS?Diagnosis and treatment of multiple sclerosis.Benign multiple sclerosis: does it exist?Prognostic risk estimates of patients with multiple sclerosis and their physicians: comparison to an online analytical risk counseling tool Multiple sclerosis: diagnosis and the management of acute relapses Multiple Sclerosis Severity Scale and whole-brain N-acetylaspartate concentration for patients' assessment.A Survey of Severity and Distribution of Musculoskeletal Pain in Multiple Sclerosis Patients; a Cross-Sectional Study.Factors associated with benign multiple sclerosis in the New York State MS Consortium (NYSMSC)Interferon-beta1b for multiple sclerosis.The conundrum of iron in multiple sclerosis--time for an individualised approach.Tract-specific white matter correlates of fatigue and cognitive impairment in benign multiple sclerosis Multiple sclerosis disease-modifying therapies: adverse effect surveillance and management.Prognosis of multiple sclerosis: clinical factors predicting the late evolution for an early treatment decision.Benign course in multiple sclerosis: a review.Depression in multiple sclerosis: a longitudinal analysis Disease-modifying drugs for multiple sclerosis: current and future aspects.Disability in multiple sclerosis: a reference for patients and clinicians.Disease Modifying Therapy in Multiple Sclerosis.Latitude and HLA-DRB1*04:05 independently influence disease severity in Japanese multiple sclerosis: a cross-sectional study Global N-acetylaspartate concentration in benign and non-benign multiple sclerosis patients of long disease duration Natural history of multiple sclerosis symptoms Diagnosis and treatment of multiple sclerosis in pediatric and adolescent patients: current status and future therapies.Treatment of multiple sclerosis in children and adolescents.Novel immunomodulatory approaches for the management of multiple sclerosis.Benign multiple sclerosis: aspects of cognition and neuroimaging.Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) in the Italian population.Combined visual and motor evoked potentials predict multiple sclerosis disability after 20 years.Primary Progressive Multiple Sclerosis Evolving From Radiologically Isolated Syndrome.A multi-biomarker follow-up study of patients with multiple sclerosis.

P2860

Q24185882-0111B534-D27B-4325-991C-05C9240BD612 Q24236597-77EB35F0-2158-4BEC-9D34-368B791343CD Q24805196-A36D8C0A-E899-4018-85A2-412140096131 Q30712257-D9CB9CE8-B432-4D4E-9290-0AA8107D43E0 Q31095962-A97F8A1B-BE01-483B-8710-37A43C340835 Q33270221-AC24287F-2717-4899-895C-16353CA3F92D Q33640136-0405AD82-240A-43D0-BD99-2BFE2CBCED47 Q33725131-317D0733-E19F-4072-AC9D-7350846909AA Q33808285-8E3D2307-C04E-4F37-B8AB-6E6A6B13703F Q34045441-6B5D340D-D7CB-4947-97AC-AE66D74AC241 Q34073979-88C589F3-3453-4F87-959F-FCC18DE3FC58 Q34390006-649CA731-1B3D-4DF5-BF55-F7B1D7C96074 Q34421883-74858898-2D9C-464A-B6C9-02587C0CF918 Q34640135-6F44C40A-6FB1-44A2-BDDF-119391595FC0 Q34729752-91B77C51-9D21-481B-B0C8-86DA6B7DFC7D Q35521828-0BBEF18D-1821-4145-BA4E-CCBF1B2CE788 Q35629319-90D12387-548F-444C-8C1D-1AD951ED3FAC Q35745861-9BCE8FBF-C08A-4477-B849-830A4D568001 Q36077974-BB0F8DD8-1F4B-4450-85F3-192533DCFB18 Q36106790-63DD87A6-F538-4E6B-B4EF-C5A5F230024D Q36110218-0B090074-0465-462F-9CAB-08CC066C152D Q36295194-74562BA7-3838-4913-B9B2-37B61DB2960E Q36419566-FBDE3A01-78B8-485E-B042-0F4F425190A9 Q36419573-7612BA31-2227-4C92-A56F-E479F1A40F0C Q36468278-EF8F843D-9814-4E1E-9CE3-AD393E8D761D Q36585597-FF4544DD-A266-4299-B967-A5E6F53E8ADB Q36613906-6D089377-28CA-46B9-AC17-B3E65940964D Q36841485-52A09046-E49C-4289-943A-67390982B44D Q36979819-64C20D40-5E8D-473A-B8A0-DBBBC67ED8A4 Q37237207-D121F236-CA1E-46D6-846C-ECDF293FCB1A Q37303007-07301CDA-FC37-4C98-92C5-403B2E6066F4 Q37442391-BE383275-B16D-495A-AF03-0A9127888FAB Q37562166-5D33ABDA-B0C7-4B9E-B97F-ACACEB9FDBB4 Q37693918-882C435A-9691-40DF-BB1A-0512F8D20435 Q38156608-EA3F5513-519E-49B1-99A3-1203D2E6FBAF Q38704455-835B6F9B-4C34-4146-9ACD-CB5D47A02263 Q38878835-C2248816-E998-4F01-8864-2F692AB75CE4 Q39436503-AF679AAE-447F-4449-BE1A-A26949990D80 Q41102123-13FE560D-8B9F-43B7-9D03-32208D66455A Q41182006-490CE2F4-E60B-4788-A04E-BEDEE1E1A4C2

P2860

Clinical implications of benign multiple sclerosis: a 20-year population-based follow-up study.

http://www.wikidata.org/entity/Q34338580

description

2004 nî lūn-bûn

@nan

2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Clinical implications of benig ...... ulation-based follow-up study.

@ast

Clinical implications of benig ...... ulation-based follow-up study.

@en

Clinical implications of benig ...... ulation-based follow-up study.

@nl

type

label

Clinical implications of benig ...... ulation-based follow-up study.

@ast

Clinical implications of benig ...... ulation-based follow-up study.

@en

Clinical implications of benig ...... ulation-based follow-up study.

@nl

prefLabel

Clinical implications of benig ...... ulation-based follow-up study.

@ast

Clinical implications of benig ...... ulation-based follow-up study.

@en

Clinical implications of benig ...... ulation-based follow-up study.

@nl

P1433

Q34338580-E23FC91E-5008-42A0-A5BB-976844CF6B98

P1476

Q34338580-10AEB531-F755-44DC-BCB3-3225166D92A9

P2093

Q34338580-27DFAFCD-C6EA-47A3-A040-CD05592E0156

Q34338580-2A998F12-916F-46D7-8175-24E14B5A3FE5

Q34338580-436D9A22-7F1D-4D01-9411-1BBE4472770C

Q34338580-45F3A1D8-43A3-48E6-B25C-E09A89A1B6C2

Q34338580-939B0E47-A8E7-4403-9A12-CEEEB4962899

Q34338580-D903E999-A944-49F3-BE93-D9AA496D646E

P2860

Q34338580-1ACF260A-8D6D-4A17-BC15-5BDA38C4F943

Q34338580-B15AED12-EBE6-4DB2-B0CB-551CAABC848F

P304

Q34338580-2F2A4EF8-BBFD-4B1A-825D-88DB0D6557E7

P31

Q34338580-A97B1CAE-09DB-46A4-AC2C-FD64847A1BEC

P356

Q34338580-9D9583A6-542B-47B0-974B-13E4510E60AB

P433

Q34338580-3FDB7F6E-39B9-4C63-807B-C11E1DBF0E8D

P478

Q34338580-BD82B554-B004-4C04-BD89-38F9C9134300

P50

Q34338580-A2F5FC2A-E3FF-4FDD-828F-B1288D5BFC2E

P577

Q34338580-3E05B7CD-57A2-4D58-ACC8-AEF9BEEB0318

P5875

Q34338580-460B47FF-D2EC-46C3-8B1C-56FDB1672825

P698

Q34338580-251D5DB9-8A85-47E3-B994-EA0EE5FB496C

P921

Q34338580-897B82EE-6E81-439B-820D-92D7E801CE53

P356

P1433

Annals of Neurology

P1476

Clinical implications of benig ...... pulation-based follow-up study

@en

P2093

Brian G Weinshenker

http://www.w3.org/2001/XMLSchema#string

John Noseworthy

http://www.w3.org/2001/XMLSchema#string

Neal W Jorgensen

http://www.w3.org/2001/XMLSchema#string

Robyn L McClelland

http://www.w3.org/2001/XMLSchema#string

Sean J Pittock

http://www.w3.org/2001/XMLSchema#string

William T Mayr

http://www.w3.org/2001/XMLSchema#string

P2860

Defining the clinical course of multiple sclerosis: Results of an international survey

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

P304

303-306

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.20197

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

56

http://www.w3.org/2001/XMLSchema#string

P50

Moses Rodriguez

P577

2004-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8417878

http://www.w3.org/2001/XMLSchema#string

P698

15293286

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis